...外还有很多问题值得进一步探索,如利巴韦林的作用机制是什么,为何有些患者易复发,有些慢应答患者(slow-responding patients)接受大剂量利巴韦林治疗后可获得持续病毒学应答(SVR),而有些患者则对利巴韦林治疗不产生任何病毒学应答等。
基于1个网页-相关网页
slow-responding patients 有些慢应答患者
Disease control lasted up to 14 months with continuous therapy, with many responding patients still receiving treatment.
控制病情的治疗持续了14个月,许多有反应的病人仍然接受了治疗。
In 2006, the same research group reported that one of the 23 "vegetative" patients showed on imaging tests that her brain was responding to commands.
2006年这个研究小组报道称,23位“植物人”中有一位病人的大脑在脑部造像测试中对指令有了反应。
In a clinical trial at UCLA's Jonsson Cancer Center and other locations, patients with BRAF-mutated metastatic melanoma have been responding very well to an experimental drug, PLX4032.
在UCLA琼森癌症研究中心和其他地方的临床试验中,一种试验药物,PLX4021,对BRAF基因变异的黑素瘤转移病人的效果很好。
应用推荐